INDUSTRY — LIFE SCIENCES

Life Sciences AI

Pharma and biotech operate in the same regulatory neighborhood as our 15-year healthcare IT practice. GxP, 21 CFR Part 11, and FDA AI guidance aren't new territory for us.

Illustration for life sciences AI

THE CONTEXT

Regulated AI in life sciences

In life sciences, every AI system touches a validation requirement. From GxP-qualified infrastructure to FDA submission documentation, the compliance architecture isn't a layer you add later — it's the foundation you design from. Our work in adjacent regulated environments means we build that way by default.

REGULATORY FRAMEWORK
21 CFR Part 11

Electronic records and signatures — the foundation of GxP compliance for AI

FDA AI/ML Guidance

Evolving FDA framework for AI/ML in drug development and medical devices

GxP Validation

Process validation requirements for AI in GMP/GCP/GLP environments

EU MDR / IVDR

European Medical Device and In Vitro Diagnostic regulations for AI-enabled devices

VALIDATED AI

Where AI creates value in life sciences

FIRST CONVERSATION

Book a life sciences AI conversation

AI GOVERNANCE